AGP Picks
View all

AGP Executive Report

Last update: 10 hours ago

Finland Alcohol Watch: THL reports recorded alcohol consumption in Finland fell 4.5% in 2025 to about 6.9 litres of pure alcohol per resident aged 15+, with declines across retail and restaurants (strong beer was the only category that grew). Long COVID Brain Clue: Finnish researchers found no widespread brain inflammation in people with long COVID; instead, scans pointed to heightened activity in emotion, stress and memory-related regions. Cancer & Heart Risk Research: A JAMA Network Open study links post-diagnostic statin use with lower mortality in early breast cancer hormone-receptor subtypes, while other studies explore new cardiovascular risk markers in HIV and immune-inflammation signals in liver cancer. Mental Health Care Policy: A Karolinska Institutet doctoral thesis says coercive measures in inpatient child and adolescent psychiatry remain common and vary widely, and that stricter Swedish rules didn’t reduce coercion. Alzheimer’s & Lithium: A Finnish-led cell study suggests lithium affects far more processes inside Alzheimer’s cells than previously mapped, potentially explaining why earlier human trial benefits were inconsistent. Biotech Pipeline: Herantis says the FDA found its HER-096 Phase 2a plan appropriate for early Parkinson’s, and 3PBIOVIAN expands mammalian biomanufacturing with an added 2,000 L bioreactor. Nutrition & Sustainability: Raisio secured funding to turn grain processing side streams into functional fiber ingredients, and an EU-backed VTT-led project (Proscale) aims to scale microbial proteins using food waste.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jun. 1, 2026

SuperCom wins $1.8 million Norway monitoring contract

EIN Presswire

fallback image
May 4, 2026

Thai university approves ethics review of Maha Taksa astrology study

EIN Presswire

fallback image
May 29, 2026

Lower protein intake linked to weaker physical function in older adults

EIN Presswire

fallback image
May 27, 2026

Matas Group taps Revieve to expand AI beauty across the Nordics

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Joseph L Morse Health Center led Palm Beach County nursing homes in Q1

Joseph L Morse Health Center led Palm Beach County nursing homes in Q1

Joseph L Morse Health Center tops Palm Beach County nursing homes in first quarter of 2026

Joseph L Morse Health Center tops Palm Beach County nursing homes in first quarter of 2026

Ex-BATTLE BEAST Frontwoman NOORA LOUHIMO Crowned Winner Of Finnish Singing Competition 'Tähdet, Tähdet' After Performing 'My Heart Will Go On'

Ex-BATTLE BEAST Frontwoman NOORA LOUHIMO Crowned Winner Of Finnish Singing Competition 'Tähdet, Tähdet' After Performing 'My Heart Will Go On'


fallback image
Jun. 1, 2026

Aplagon Announces Review Publication on APAC, a First-in-Class Dual-Action Antithrombotic to Treat Unmet Clinical Needs in Thromboinflammatory Diseases

GlobeNewswire, Inc.

fallback image
May 30, 2026

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

GlobeNewswire, Inc.

fallback image
May 26, 2026

Public Health Command Europe Hosts 71st International Military Veterinary Exchange

DVIDS - Georgia

fallback image
May 21, 2026

Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting

GlobeNewswire, Inc.

fallback image
Jun. 2, 2026

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096

GlobeNewswire, Inc.

fallback image
May 19, 2026

Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Hundreds of Russian Strikes Across Ukraine Kill at Least 14 People
Play
Hundreds of Russian Strikes Across Ukraine Kill at Least 14 People
YouTube video thumbnail: Russia 'Trying to Prevent Armenia's Diversification of Connectivity', Expert Says
Play
Russia 'Trying to Prevent Armenia's Diversification of Connectivity', Expert Says
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: EU Greenlights Controversial Return Hubs in 'Strictest-Ever' New Migration Law
Play
EU Greenlights Controversial Return Hubs in 'Strictest-Ever' New Migration Law
YouTube video thumbnail: After Oil Shale: Are Magnets the Next big Business for Europe?
Play
After Oil Shale: Are Magnets the Next big Business for Europe?

Video Title

Sign up for:

Health Daily Finland

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Health Daily Finland

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.